Related Experiment Video
Updated: May 23, 2026

07:41
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Closure of interatrial defects by immediate-release patch
Aliakbar Zeinaloo1, Keyhan Sayadpour Zanjani, Bahman Rastkar
1Children's Medical Center, Tehran University of Medical Sciences, 62 Dr Gharib Street, 14194, Tehran, Iran.
Pediatric Cardiology
|March 29, 2012
Summary
The novel Immediate-Release Patch offers a wireless, bioabsorbable solution for closing cardiac defects. While generally successful, some residual shunts may occur, requiring further evaluation.
Area of Science:
- Cardiovascular Medicine
- Biomaterials Science
- Medical Devices
Background:
- Cardiac defects necessitate effective closure methods.
- Transcatheter devices offer less invasive treatment options.
- Bioabsorbable materials present advantages in medical implants.
Purpose of the Study:
- To evaluate the safety and efficacy of the Immediate-Release Patch for cardiac defect closure.
- To assess the performance of this novel bioabsorbable device in clinical practice.
Main Methods:
- The Immediate-Release Patch was used to attempt closure of 12 atrial septal defects and 1 fenestration.
- Device implantation success, retrieval, and adverse events were recorded.
- Follow-up assessments evaluated residual shunts and defect closure status.
Main Results:
- Successful implantation was achieved in 12 out of 13 attempted procedures.
- One device dislodged and was percutaneously retrieved; no other major adverse events were reported.
- At a median 11-month follow-up, two patients had trivial residual shunts, and one had a significant residual defect.
Conclusions:
- The Immediate-Release Patch demonstrates potential as a wireless, bioabsorbable device for cardiac defect closure, with advantages in specific defect types and sizes.
- The device's bulkiness and application method require operator adaptation.
- Further studies are needed to optimize outcomes and minimize residual shunts.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

